Minerva Neurosciences(NERV)
BURLINGTON, MABiotechnology
Focus: Minerva Neurosciences is a public biotech company focused on CNS treatments, particularly for neurological and psychiatric disorders. The company operates at a pre-revenue or minimal-revenue stage with a lean R&D footprint.
Profile data last refreshed 5h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
6+6 this month
Growing — net +6 jobs in 30d
6 jobs added vs 0 removed. Steady team buildout.
Should You Work at Minerva Neurosciences?
AI assessmentHigh-risk, early-stage play suitable only for scientists seeking maximum upside and risk tolerance; immediate hiring freeze and cash constraints suggest near-term headcount reductions are likely.
Why Work Here
- Early-stage pipeline focused on high-unmet-need CNS indications (schizophrenia, depression) with multiple Phase 1/2 programs
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
MIN-101
SchizophreniaClinical Trials (1)
NCT02232529Pharmacokinetic Study of MIN-101 in Healthy Subjects
Phase 1Help build intelligence for Minerva Neurosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.